Loading...
Progyny, Inc.
PGNY•NASDAQ
Healthcare
Medical - Healthcare Information Services
$23.11
$0.11(0.48%)
Progyny, Inc. (PGNY) Financial Performance & Income Statement Overview
Review Progyny, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.22%
↑ 7.22%
Operating Income Growth
8.48%
↑ 8.48%
Net Income Growth
-12.41%
↓ 12.41%
Operating Cash Flow Growth
-5.14%
↓ 5.14%
Operating Margin
6.03%
↑ 6.03%
Gross Margin
21.99%
↑ 21.99%
Net Profit Margin
4.33%
↑ 4.33%
ROE
11.80%
↑ 11.80%
ROIC
14.82%
↑ 14.82%
Progyny, Inc. (PGNY) Income Statement & Financial Overview
Review Progyny, Inc.'s (PGNY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $298.43M | $286.63M | $304.09M | $278.08M |
| Cost of Revenue | $235.00M | $227.38M | $235.81M | $215.67M |
| Gross Profit | $63.43M | $59.24M | $68.28M | $62.41M |
| Gross Profit Ratio | $0.21 | $0.21 | $0.22 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $47.65M | $46.79M | $47.59M | $43.88M |
| Operating Expenses | $47.65M | $46.79M | $47.59M | $43.88M |
| Total Costs & Expenses | $282.64M | $274.17M | $283.40M | $259.56M |
| Interest Income | $1.87M | $5.50M | $816000.00 | $632000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $868000.00 | $0.00 | $754000.00 | $716000.00 |
| EBITDA | $16.66M | $12.46M | $21.44M | $19.24M |
| EBITDA Ratio | $0.06 | $0.04 | $0.07 | $0.07 |
| Operating Income | $15.79M | $12.46M | $20.69M | $18.52M |
| Operating Income Ratio | $0.05 | $0.04 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | $1.87M | $5.50M | $4.38M | $3.99M |
| Income Before Tax | $17.66M | $17.96M | $25.07M | $22.52M |
| Income Before Tax Ratio | $0.06 | $0.06 | $0.08 | $0.08 |
| Income Tax Expense | $7.13M | $7.54M | $8.58M | $5.62M |
| Net Income | $10.53M | $10.42M | $16.48M | $16.90M |
| Net Income Ratio | $0.04 | $0.04 | $0.05 | $0.06 |
| EPS | $0.12 | $0.12 | $0.18 | $0.18 |
| Diluted EPS | $0.12 | $0.11 | $0.17 | $0.17 |
| Weighted Avg Shares Outstanding | $85.81M | $90.07M | $93.87M | $96.48M |
| Weighted Avg Shares Outstanding (Diluted) | $88.91M | $93.82M | $97.84M | $101.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan